SocietyWithMS

Society with MS is dissolved/no longer in existence. Please follow @solvingms

[SocietyWithMS @SocietyWithMS]

@SolvingMS is tracking anti-EBV therapies in the MS Research Database. These can be grouped into 3 different approaches.

[SocietyWithMS @SocietyWithMS]

Society with MS is dissolved/no longer in existence. Please follow @solvingms

[Barry Singer MD 🧠 @drbarrysinger]

Graves: New #MS monitoring tool using wearable multi-sensor on forearm and leg. Uses gyroscope, accelerometer and surface EMG.
FMSight collects afferent & efferent visual function with mobile brain 🧠 💻 interface. #ACTRIMS2023 #ACTRIMSForum @neurology_live

[Barry Singer MD 🧠 @drbarrysinger]

Two ongoing #vaccine trials to prevent #EBV Epstein-Barr infection. Goal: To prevent #MS and reduce disease activity.
👉Today I’m doing a Twitter takeover for @neurology_live! @AaronBosterMD NerdyNeuroMD @Brandon_Beaber @DocforMS @KlausSchmierer @MustStopMS @themsguide

[SocietyWithMS @SocietyWithMS]

Lawrence Steinman, MD, received the 2023 Pioneer in Medicine Award for his contributions in identifying the similarities between the Epstein-Barr virus (EBV) protein EBNA-1 and the brain protein GlialCAM aka molecular mimicry.

[Barry Singer MD 🧠 @drbarrysinger]

Steinman: Epstein-Barr virus #EBV may trigger #MS via molecular mimicry. #EBV immune responses could cross react with chloride channels, myelin basic protein and CNS adhesion molecule glialCAM. #ACTRIMS2023 #ACTRIMSForum

[SocietyWithMS @SocietyWithMS]

SWiMS has been laser-focused on latent EBV as a trigger of MS following the seminal studies from Harvard & Stanford Jan 2022 confirming this. Wonderful to see so many great presentations on this at #ACTRIMS2023!

[Barry Singer MD 🧠 @drbarrysinger]

Jacobson @NIH reveals trials clinical trials for #MS that tackle 🦠 viral trigger. Focus on #EBV Epstein-Barr #virus.
🗝️❓Is #MS prevention and disease reduction possible with an anti-viral approach? #ACTRIMS2023 #ACTRIMSForum @neurology_live @C_OrejaGuevara @GavinGiovannoni

[SocietyWithMS @SocietyWithMS]

@NeuroscienceNew Green tee is also an aryl hydrocarbon receptor agonist. But I think there are plenty of people with MS sipping green tea and I haven't heard of it making a big impact.

https://t.co/ktKFE9aO8H

[SocietyWithMS @SocietyWithMS]

@NeuroscienceNew An AHR agonist drug approved in 2022 for an AI drug - psoriasis. This could make it faster to other AI disease like MS.

https://t.co/eEjJadApKj

[SocietyWithMS @SocietyWithMS]

@BrianRoemmele Great!
Thus, these pigments of green tea leaves have the potential to protect from dioxin toxicity through the suppression of AhR transformation.

[SocietyWithMS @SocietyWithMS]

Australia is an innovator in MS research and treatment!

[MStranslate @MStranslate]

Great to see the depth & breadth of #MultipleSclerosis research that @MS_Australia has supported via its latest round of grants. We look forward to following the progress of each study. Good luck to the researchers pursuing these important projects. #MS https://t.co/9BKLTNxvSk

[SocietyWithMS @SocietyWithMS]

#EBVcausesMS Now let's cure it!

[Barry Singer MD 🧠 @drbarrysinger]

Steinman: Epstein-Barr virus #EBV may trigger #MS via molecular mimicry. #EBV immune responses could cross react with chloride channels, myelin basic protein and CNS adhesion molecule glialCAM. #ACTRIMS2023 #ACTRIMSForum

[Dr. Brandon Beaber @Brandon_Beaber]

Dr. Lawrence Steinman has ambitions to use anti-EBV therapies to "potentially eradicate MS, as we have done with nearly complete success for poliomyelitis." https://t.co/nahjnXmgfD

[NervGen @NervgenP]

Torrey Hills Zoom https://t.co/ioQmJdeK7f via @YouTube

[SocietyWithMS @SocietyWithMS]

@bam214_bam @klstenhouse Hang in there, enough researchers are writing about this now so we should start to see some human trials starting.

[SocietyWithMS @SocietyWithMS]

See this discussion about the recent studies adding to the accumulating evidence that #EBVcausesMS which has long been proposed by @GavinGiovannoni

[KStenhouse @klstenhouse]

Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells
https://t.co/rXWjr5i56k
Why yes, for me, it does. Actual bloodwork and data. Being unable to get help because "it's still in research" is exhausting. #MS #EBVcausesMS #preprint

[SocietyWithMS @SocietyWithMS]

If your New Year resolution was to do more exercise to keep MS in check you are on the right track!

[SocietyWithMS @SocietyWithMS]

Add your votes!

[MStranslate @MStranslate]

VOTE NOW: If I had to choose what the next #MultipleSclerosis medication did, I would want one that…

[SocietyWithMS @SocietyWithMS]

@MStranslate Trial of exercise for remyelination in MS.
https://t.co/WflvtMbqAU

[SocietyWithMS @SocietyWithMS]

@GavinGiovannoni New confirmation #EBVcausesMS Jan 2023 @Dr_Gulfaraz @GavinGiovannoni
https://t.co/Dh3Jqsbnkw

[SocietyWithMS @SocietyWithMS]

@GavinGiovannoni @SocietyWithMS is a 501(c)3 nonprofit founded by patients determined to speed #MScure 3400 members strong. We are ready to assist you w/ funding a trial for #EBVcausesMS.